Related Research Articles
Huntington's disease (HD), also known as Huntington's chorea, is an incurable neurodegenerative disease that is mostly inherited. The earliest symptoms are often subtle problems with mood or mental/psychiatric abilities. A general lack of coordination and an unsteady gait often follow. It is also a basal ganglia disease causing a hyperkinetic movement disorder known as chorea. As the disease advances, uncoordinated, involuntary body movements of chorea become more apparent. Physical abilities gradually worsen until coordinated movement becomes difficult and the person is unable to talk. Mental abilities generally decline into dementia, depression, apathy, and impulsivity at times. The specific symptoms vary somewhat between people. Symptoms usually begin between 30 and 50 years of age, and can start at any age but are usually seen around the age of 40. The disease may develop earlier in each successive generation. About eight percent of cases start before the age of 20 years, and are known as juvenile HD, which typically present with the slow movement symptoms of Parkinson's disease rather than those of chorea.
The Stanford University School of Medicine is the medical school of Stanford University and is located in Stanford, California, United States. It traces its roots to the Medical Department of the University of the Pacific, founded in San Francisco in 1858. This medical institution, then called Cooper Medical College, was acquired by Stanford in 1908. The medical school moved to the Stanford campus near Palo Alto, California, in 1959.
Vijay Satyanand Pande is a Trinidadian–American scientist and venture capitalist. Pande is the former director of the biophysics program and is best known for orchestrating the distributed computing disease research project known as Folding@home. His research is focused on distributed computing and computer-modelling of microbiology and on improving computer simulations regarding drug-binding, protein design, and synthetic bio-mimetic polymers. Pande became the ninth general partner at venture capital firm Andreessen Horowitz in November 2015. He is the founding investor of their Bio + Health Fund.
Logan Maile Lei Tom is an American former indoor volleyball and beach volleyball player, and is the current head coach of the Israel women's national volleyball team. She is a four-time Olympian at the outside hitter position. At age 19, Logan became the youngest woman ever to be selected for an American Olympic volleyball team when she competed at the 2000 Olympic Games in Sydney. She is a skilled all-around player who brings stability to the American serve receive and defense, while also providing the team with a solid attack and block at the net. She had been a huge part of the national team from 2000 to 2012. At the 2008 Olympics, Tom helped Team USA win a silver medal and was named Best Scorer, she won another silver medal at the 2012 Olympics with the national team. She was also awarded the Most Valuable Player of the 2004 FIVB World Grand Prix.
Daphne Koller is an Israeli-American computer scientist. She was a professor in the department of computer science at Stanford University and a MacArthur Foundation fellowship recipient. She is one of the founders of Coursera, an online education platform. Her general research area is artificial intelligence and its applications in the biomedical sciences. Koller was featured in a 2004 article by MIT Technology Review titled "10 Emerging Technologies That Will Change Your World" concerning the topic of Bayesian machine learning.
Spinocerebellar ataxia (SCA) is a progressive, degenerative, genetic disease with multiple types, each of which could be considered a neurological condition in its own right. An estimated 150,000 people in the United States have a diagnosis of spinocerebellar ataxia at any given time. SCA is hereditary, progressive, degenerative, and often fatal. There is no known effective treatment or cure. SCA can affect anyone of any age. The disease is caused by either a recessive or dominant gene. In many cases people are not aware that they carry a relevant gene until they have children who begin to show signs of having the disorder.
Carolyn Ruth Bertozzi is an American chemist and Nobel laureate, known for her wide-ranging work spanning both chemistry and biology. She coined the term "bioorthogonal chemistry" for chemical reactions compatible with living systems. Her recent efforts include synthesis of chemical tools to study cell surface sugars called glycans and how they affect diseases such as cancer, inflammation, and viral infections like COVID-19. At Stanford University, she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences. Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) and is the former director of the Molecular Foundry, a nanoscience research center at Lawrence Berkeley National Laboratory.
Diane B. Greene is an American technology entrepreneur and executive. Greene started her career as a naval architect before transitioning to the tech industry, where she was a founder and CEO of VMware from 1998 until 2008. She was a board director of Google and CEO of Google Cloud from 2015 until 2019. She was also the co-founder and CEO of two startups, Bebop and VXtreme, which were acquired by Google and Microsoft, for $380 million and $75 million.
Lucy Shapiro is an American developmental biologist. She is a professor of Developmental Biology at the Stanford University School of Medicine. She is the Virginia and D.K. Ludwig Professor of Cancer Research and the director of the Beckman Center for Molecular and Genetic Medicine.
Elena Cattaneo is an Italian pharmacologist and co-founding director of the University of Milan's Center for Stem Cell Research.
Don W. Cleveland is an American cancer biologist and neurobiologist.
Daria Hennadiyivna Bilodid is a Ukrainian judoka. She is the 2019 World and the 2019 European gold medalist in the 48 kg division. In 2021, she won one of the bronze medals in the women's 48 kg event at the 2020 Summer Olympics in Tokyo, Japan.
Anne Jennifer Morton,, known as Jenny Morton, is a New Zealand neurobiologist and academic, specialising in neurodegenerative diseases. She has been a Fellow of Newnham College, Cambridge, since 1991 and a Professor of Neurobiology at the University of Cambridge since 2009. Her current research is focused on Huntington's disease, and she is using sheep as a large animal model for the disease. This research has led her to discover that sheep can recognise human faces.
Katharina Sophia Volz is a medical researcher and entrepreneur. She is the founder and chief executive officer of OccamzRazor, a biotechnology start-up based in New York City and San Francisco, which is searching for cures for incurable diseases. Powered by revolutionary machine learning technology, OccamzRazor harnesses the world's scientific information to discover and develop drugs for brain diseases – much faster and more effectively than ever before.
Michele Barry is a professor of medicine. She became Stanford's inaugural Senior Associate Dean of global health in 2009 and started the Stanford Center for Innovation in Global Health in 2010. Prior to this, she was a professor at Yale, where she started the first refugee health clinic and homeless health mobile van project, for which she was awarded the Elm Ivy Mayor’s Award. She specializes in tropical medicine, emerging infectious diseases, women’s leadership in global health, and human and planetary health.
Cathy Tie is a Canadian bioinformatician and entrepreneur, the founder of Ranomics, a genetic screening company, and of Locke Bio, a telemedicine company, both based in Toronto.
Suchi Saria is an Associate Professor of Machine Learning and Healthcare at Johns Hopkins University, where she uses big data to improve patient outcomes. She is a World Economic Forum Young Global Leader. From 2022 to 2023, she was an investment partner at AIX Ventures. AIX Ventures is a venture capital fund that invests in artificial intelligence startups.
Yvonne "Bonnie" Maldonado is an American physician, pediatrician, and Professor of Pediatrics and of Health Research and Policy at Stanford University, with a focus on Infectious Diseases. She founded Stanford's pediatric HIV Clinic and now serves as Stanford University School of Medicine's Senior Associate Dean of Faculty Development and Diversity.
Varda Shalev is an Israeli medical researcher,a professor of medicine at the Tel Aviv University School of Public Health, and a primary care physician. She is also the co-founder and Chief Medical Officer of Alike. In 11.2022 she became a managing partner at Team8 foundry.
Elizabeth Patton, Ph.D FRSE is professor of chemical genetics and group leader of Medical Research Council Institute for Genetics and Molecular Medicine (IGMM) Human Genetics Unit in Edinburgh, Personal Chair of Melanoma Genetics and Drug Discovery for a disease which kills 20,000 Europeans a year, and accounts for 80% of all skin cancer deaths. Her research into the genetic models and drug interactions testing, sharing international findings, is mainly using zebrafish in conjunction with the Edinburgh Cancer Research Centre. She holds a number of academic leadership roles in UK, Europe and international scientific bodies.
References
- ↑ "Daria Mochly-Rosen". Stanford University . Retrieved 2018-08-12.
- ↑ "Neurological therapy co Mitoconix Bio raises $20m". Globes. Retrieved 2017-06-27.
- ↑ "California Life Sciences Association (CLSA) Adds Leaders from City of Hope, Stanford to Board of Directors" . Retrieved 2017-02-13.[ permanent dead link ]
- ↑ Danney, Micah (2017-07-05). "Israeli startup takes aim at Huntington's disease". The Times of Israel . Retrieved 2018-08-12.
